ARCHIVES

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | March 19, 1999

Download PDF Visit The Full Archive

Related Articles

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

Funding Opportunities: PAs Available.

January 28, 2005

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Another HHS Recommendation: Screen 50 And Older For Colorectal Cancer;

March 15, 2002